Research Options:
Select below
IPO Calendar
Week of Expected Pricing
Pending
Company Name
Reliant pharmaceuticals, Inc.
Proposed Ticker
RRX
CUSIP
75953J107
Business Description
A rapidly growing pharmaceutical company that specializes in the development, commercialization and marketing of prescription therapeutic products.
Lead Underwriter
Goldman, Sachs & Co, Merrill Lynch & Co.
Co-Managers
JPMorgan, Bank of America Securities LLC, Lazard Capital Markets
Initial Shares
N/A
Revised Initial Shares
N/A
Initial Price
N/A
Revised Price
N/A
Final Price
N/A
Final Ticker
N/A
© 2024 ICE Data Services. All rights reserved.